Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset

被引:51
|
作者
Wynberg, Elke [1 ,2 ]
van Willigen, Hugo D. G. [2 ,3 ]
Dijkstra, Maartje [1 ,2 ]
Boyd, Anders [1 ,4 ]
Kootstra, Neeltje A. [5 ]
van den Aardweg, Joost G. [6 ]
van Gils, Marit J. [3 ]
Matser, Amy [1 ]
de Wit, Marije R. [1 ]
Leenstra, Tjalling [1 ]
de Bree, Godelieve [2 ]
de Jong, Menno D. [3 ]
Prins, Maria [1 ,2 ]
机构
[1] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Amsterdam Inst Infect & Immun, Dept Infect Dis, Amsterdam, Netherlands
[3] Univ Amsterdam, Amsterdam Inst Infect & Immun, Dept Med Microbiol & Infect Prevent, Amsterdam UMC, Amsterdam, Netherlands
[4] Stichting Human Immunodeficiency Virus HIV Monito, Amsterdam, Netherlands
[5] Univ Amsterdam, Amsterdam Inst Infect & Immun, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands
[6] Univ Amsterdam, Dept Pulmonol, Amsterdam UMC, Amsterdam, Netherlands
关键词
Long COVID; symptoms; recovery;
D O I
10.1093/cid/ciab759
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In our cohort, post-coronavirus disease (COVID) syndrome was common, even in those with mild disease. Recovery from symptoms beyond 6 months after illness onset was rare. Importantly, female and obese participants recovered more slowly, regardless of age or comorbidities. Background Few robust longitudinal data on long-term coronavirus disease 2019 (COVID-19) symptoms are available. We evaluated symptom onset, severity and recovery across the full spectrum of disease severity, up to one year after illness onset. Methods The RECoVERED Study is a prospective cohort study based in Amsterdam, the Netherlands. Participants aged >= 18 years were enrolled following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis via the local public health service and from hospitals. Standardized symptom questionnaires were completed at enrollment, 1 week and month later, and monthly thereafter. Clinical severity was defined according to World Health Organization (WHO) criteria. Kaplan-Meier methods were used to compare time from illness onset to symptom recovery, by clinical severity. We examined determinants of time to recovery using multivariable Cox proportional hazards models. Results Between 11 May 2020 and 1 May 2021, 342 COVID-19 patients (192 [56%] male) were enrolled, of whom 99/342 (29%) had mild, 145/342 (42%) moderate, 56/342 (16%) severe, and 42/342 (12%) critical disease. The proportion of participants who reported at least 1 persistent symptom at 12 weeks after illness onset was greater in those with severe/critical disease (86.7% [95% confidence interval {CI} = 76.5-92.7%]) compared to those with mild or moderate disease (30.7% [95% CI = 21.1-40.9%] and 63.8% [95% CI = 54.8-71.5%], respectively). At 12 months after illness onset, two-fifths of participants (40.7% [95% CI = 34.2-7.1]) continued to report >= 1 symptom. Recovery was slower in female compared to male participants (adjusted hazard ratio [aHR] 0.65 [95% CI = .47-.92]) and those with a body mass index [BMI] >= 30kg/m(2) compared to BMI <25kg/m(2) (hazard ratio [HR] 0.62 [95% CI = .39-.97]). Conclusions COVID-19 symptoms persisted for one year after illness onset, even in some individuals with mild disease. Female sex and obesity were the most important determinants of speed of recovery from symptoms.
引用
收藏
页码:E482 / E490
页数:9
相关论文
共 50 条
  • [21] Atypical presentations of coronavirus disease 2019 (COVID-19) from onset to readmission
    Yang, Zhiqi
    Chen, Xiaofeng
    Huang, Ruibin
    Li, Shengkai
    Lin, Daiying
    Yang, Zhijian
    Sun, Hongfu
    Liu, Guorui
    Qiu, Jinming
    Tang, Yanyan
    Xiao, Jianning
    Liao, Yuting
    Wu, Xianheng
    Wu, Renhua
    Chen, Xiangguang
    Dai, Zhuozhi
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [22] Symptoms of Dry Eye Disease in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19)
    Wang, Yan
    Yang, Sen
    Zhang, Yue
    Zhang, Xin
    Jiang, Yaping
    Wang, Xixi
    Zheng, Pengxiang
    Chen, Yihui
    [J]. JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [23] Coronavirus disease 2019 (COVID-19) and Long COVID
    Chang, Yoon-Seok
    [J]. ASIA PACIFIC ALLERGY, 2022, 12 (02)
  • [24] Post-COVID-19 condition symptoms 12 and 24 months after COVID-19 during the first month of the pandemic in Melbourne: a cohort study
    Ling, Dorothy Q.
    Gibney, Grace
    James, Fiona
    Holmes, Natasha E.
    Chua, Kyra Y. L.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2024, 220 (06) : 336 - 338
  • [25] Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?
    Lewandowski, Konrad
    Kaniewska, Magdalena
    Rosolowski, Mariusz
    Tworek, Adam
    Rydzewska, Grazyna
    [J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2022, 17 (03): : 219 - 226
  • [26] Prevalence of and Factors Associated With Post-Coronavirus Disease 2019 (COVID-19) Condition in the 12 Months After the Diagnosis of COVID-19 in Adults Followed in General Practices in Germany
    Kostev, Karel
    Smith, Lee
    Koyanagi, Ai
    Jacob, Louis
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [28] Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
    Kujawski S.A.
    Wong K.K.
    Collins J.P.
    Epstein L.
    Killerby M.E.
    Midgley C.M.
    Abedi G.R.
    Ahmed N.S.
    Almendares O.
    Alvarez F.N.
    Anderson K.N.
    Balter S.
    Barry V.
    Bartlett K.
    Beer K.
    Ben-Aderet M.A.
    Benowitz I.
    Biggs H.M.
    Binder A.M.
    Black S.R.
    Bonin B.
    Bozio C.H.
    Brown C.M.
    Bruce H.
    Bryant-Genevier J.
    Budd A.
    Buell D.
    Bystritsky R.
    Cates J.
    Charles E.M.
    Chatham-Stephens K.
    Chea N.
    Chiou H.
    Christiansen D.
    Chu V.
    Cody S.
    Cohen M.
    Conners E.E.
    Curns A.T.
    Dasari V.
    Dawson P.
    DeSalvo T.
    Diaz G.
    Donahue M.
    Donovan S.
    Duca L.M.
    Erickson K.
    Esona M.D.
    Evans S.
    Falk J.
    [J]. NATURE MEDICINE, 2020, 26 (06) : 861 - +
  • [29] Smoking and coronavirus disease 2019 (COVID-19)
    Underner, M.
    Peiffer, G.
    Perriot, J.
    Jaafari, N.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2020, 37 (05) : 433 - 436
  • [30] The management of coronavirus disease 2019 (COVID-19)
    Liu, Jialin
    Liu, Siru
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1484 - 1490